Neuromuscular cardiomyopathies

Forum Kamdar; Pradeep P.A. Mammen; Daniel J. Garry

doi:10.1007/978-3-319-44577-9_12

Neuromuscular cardiomyopathies

Forum Kamdar, Pradeep P.A. Mammen, Daniel J. Garry

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

More than 30 types of muscular dystrophies are included in the broader group of neuromuscular cardiomyopathies. Skeletal muscle weakness is a defining characteristic of muscular dystrophy, but as treatments improve and patients live longer, cardiomyopathy has emerged as the leading cause of death for patients with Duchenne or Becker muscular dystrophy. This chapter focuses on Duchenne and Becker muscular dystrophies, from their genetic origins, symptoms and disease progression to cardiac involvement and treatments, as well as research findings. Promising emerging therapies include exon skipping, dystrophin mini-gene replacement, sealants, and gene-editing strategies.

Original language	English (US)
Title of host publication	Congestive Heart Failure and Cardiac Transplantation
Subtitle of host publication	Clinical, Pathology, Imaging and Molecular Profiles
Publisher	Springer International Publishing
Pages	175-196
Number of pages	22
ISBN (Electronic)	9783319445779
ISBN (Print)	9783319445755
DOIs	https://doi.org/10.1007/978-3-319-44577-9_12
State	Published - Jun 1 2017

Keywords

Becker muscular dystrophy
Duchenne muscular dystrophy
Dystrophin gene
Dystrophinopathies
Exon skipping
Gene editing
Neuromuscular cardiomyopathies

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-319-44577-9_12

Cite this

@inbook{7c86c77e66a2427b9067d600aca1db3a,

title = "Neuromuscular cardiomyopathies",

abstract = "More than 30 types of muscular dystrophies are included in the broader group of neuromuscular cardiomyopathies. Skeletal muscle weakness is a defining characteristic of muscular dystrophy, but as treatments improve and patients live longer, cardiomyopathy has emerged as the leading cause of death for patients with Duchenne or Becker muscular dystrophy. This chapter focuses on Duchenne and Becker muscular dystrophies, from their genetic origins, symptoms and disease progression to cardiac involvement and treatments, as well as research findings. Promising emerging therapies include exon skipping, dystrophin mini-gene replacement, sealants, and gene-editing strategies.",

keywords = "Becker muscular dystrophy, Duchenne muscular dystrophy, Dystrophin gene, Dystrophinopathies, Exon skipping, Gene editing, Neuromuscular cardiomyopathies",

author = "Forum Kamdar and Mammen, {Pradeep P.A.} and Garry, {Daniel J.}",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing AG 2017.",

year = "2017",

month = jun,

day = "1",

doi = "10.1007/978-3-319-44577-9_12",

language = "English (US)",

isbn = "9783319445755",

pages = "175--196",

booktitle = "Congestive Heart Failure and Cardiac Transplantation",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Neuromuscular cardiomyopathies

AU - Kamdar, Forum

AU - Mammen, Pradeep P.A.

AU - Garry, Daniel J.

N1 - Publisher Copyright: © Springer International Publishing AG 2017.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - More than 30 types of muscular dystrophies are included in the broader group of neuromuscular cardiomyopathies. Skeletal muscle weakness is a defining characteristic of muscular dystrophy, but as treatments improve and patients live longer, cardiomyopathy has emerged as the leading cause of death for patients with Duchenne or Becker muscular dystrophy. This chapter focuses on Duchenne and Becker muscular dystrophies, from their genetic origins, symptoms and disease progression to cardiac involvement and treatments, as well as research findings. Promising emerging therapies include exon skipping, dystrophin mini-gene replacement, sealants, and gene-editing strategies.

AB - More than 30 types of muscular dystrophies are included in the broader group of neuromuscular cardiomyopathies. Skeletal muscle weakness is a defining characteristic of muscular dystrophy, but as treatments improve and patients live longer, cardiomyopathy has emerged as the leading cause of death for patients with Duchenne or Becker muscular dystrophy. This chapter focuses on Duchenne and Becker muscular dystrophies, from their genetic origins, symptoms and disease progression to cardiac involvement and treatments, as well as research findings. Promising emerging therapies include exon skipping, dystrophin mini-gene replacement, sealants, and gene-editing strategies.

KW - Becker muscular dystrophy

KW - Duchenne muscular dystrophy

KW - Dystrophin gene

KW - Dystrophinopathies

KW - Exon skipping

KW - Gene editing

KW - Neuromuscular cardiomyopathies

UR - http://www.scopus.com/inward/record.url?scp=85054644674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054644674&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-44577-9_12

DO - 10.1007/978-3-319-44577-9_12

M3 - Chapter

AN - SCOPUS:85054644674

SN - 9783319445755

SP - 175

EP - 196

BT - Congestive Heart Failure and Cardiac Transplantation

PB - Springer International Publishing

ER -

Neuromuscular cardiomyopathies

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this